In March 2025, the company announced new options for just a direct-to-purchaser presenting of its Wegovy weight loss drug. The company established a new pharmacy, named NovoCare, which would cost consumers $499 a month for use of the drug, below 50 % the price of the drug as a result of other pharmaceutical distribution networks.[fifty three]This l